Innovent Biologics
Rachel Deng is an accomplished professional in corporate strategy and business development, currently serving as Vice President at Innovent Biologics since March 2018, where responsibilities include corporate strategy, portfolio management, and alliance management. Prior to this role, Rachel held various positions at Roche from 2010 to 2018, culminating in the role of APAC Disease Area Director for Pipeline Strategic Planning. Rachel's earlier experience includes consulting and analytical roles at IMS Health and a marketing specialist position at Shanghai Pharmaceutical Group. Academic credentials include a Bachelor's degree in International Economics from Shanghai University of International Business and Economics, along with management training from Shanghai University of Finance and Economics.